What's Happening?
SelectQuote, Inc. has reported its financial results for the third quarter of fiscal year 2026, showing a consolidated revenue of $430.9 million, up from $408.2 million in the same quarter of the previous year. The company also reported a net income of $40.2
million, a significant increase from $26.0 million in the prior year. Adjusted EBITDA for the quarter was $44.6 million, compared to $37.7 million in the previous year. Despite market shifts in Medicare Advantage and prescription drugs, SelectQuote has maintained consistent profit and cash flow, driven by its operating execution and technology advantages.
Why It's Important?
SelectQuote's strong financial performance highlights its resilience and adaptability in a shifting market environment. The company's ability to deliver consistent profit and cash flow growth is crucial for its long-term sustainability and competitiveness. The results reflect the effectiveness of SelectQuote's business model, which leverages technology and skilled agents to provide value to policyholders. The company's financial health positions it well for future growth, particularly in expanding its SelectRx business and improving its capital structure.
What's Next?
SelectQuote plans to continue focusing on driving reliable profit and cash flow growth. The company aims to expand its cash flow in the coming years by leveraging its improved capital structure and the maturation of its SelectRx business. SelectQuote will also host a conference call with the investment community to discuss its financial results and future outlook. The company remains committed to enhancing its service offerings and maintaining its competitive edge in the insurance market.
